Downregulation of IRAIN long non-coding RNA predicts unfavourable clinical outcome in acute myeloid leukaemia patients

References

• Arber, D.A., et al., 2016. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood, 127 (20), 2391–2405.
   PubMed Web of Science ®Google Scholar
• Beck, D., et al., 2018. A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients. Leukemia, 32 (2), 263–272.
   PubMed Web of Science ®Google Scholar
• Bennett, J.M., et al., 1985. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Annals of internal medicine, 103 (4), 620–625.
   PubMed Web of Science ®Google Scholar
• Cabili, M.N., et al., 2011. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes & development, 25 (18), 1915–1927.
   PubMed Web of Science ®Google Scholar
• Chapuis, N., et al., 2010. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody. Haematologica, 95 (3), 415–423.
   PubMed Web of Science ®Google Scholar
• De Clara, E., et al., 2017. Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients. Haematologica, 102 (10), 1718–1726.
   PubMed Web of Science ®Google Scholar
• Derrien, T., et al., 2012. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome research, 22 (9), 1775–1789.
   PubMed Web of Science ®Google Scholar
• Djebali, S., et al., 2012. Landscape of transcription in human cells. Nature, 489 (7414), 101–108.
   PubMed Web of Science ®Google Scholar
• Döhner, H., et al., 2017. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood, 129 (4), 424–447.
   PubMed Web of Science ®Google Scholar
• Döhner, H., Weisdorf, D.J., and Bloomfield, C.D., 2015. Acute myeloid leukemia. The New England journal of medicine, 373 (12), 1136–1152.
   PubMed Web of Science ®Google Scholar
• Engreitz, J.M., et al., 2016. Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature, 539 (7629), 452–455.
   PubMed Web of Science ®Google Scholar
• Feng, J., et al., 2015. A novel long noncoding RNA IRAIN regulates cell proliferation in non small cell lung cancer. International journal of clinical and experimental pathology, 8 (10), 12268–12275.
   PubMed Web of Science ®Google Scholar
• Fürstenberger, G., and Senn, H.J., 2002. Insulin-like growth factors and cancer. The lancet oncology, 3 (5), 298–302.
   PubMed Web of Science ®Google Scholar
• Garg, M., et al., 2015. Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse. Blood, 126 (22), 2491–2501.
   PubMed Web of Science ®Google Scholar
• Garzon, R., et al., 2014. Expression and prognostic impact of lncRNAs in acute myeloid leukemia. Proceedings of the national academy of sciences of the United States of America, 111 (52), 18679–18684.
   PubMed Web of Science ®Google Scholar
• Grimwade, D., et al., 2010. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood, 116 (3), 354–365.
   PubMed Web of Science ®Google Scholar
• Guo, A., et al., 2022. Overexpression of lncRNA IRAIN restrains the progression and Temozolomide resistance of glioma via repressing IGF-1R-PI3K-NF-κB signaling pathway. Histology and histopathology, 37 (6), 543–554.
   PubMed Web of Science ®Google Scholar
• Hola, M.A.M., et al., 2021. Expression and prognostic relevance of long noncoding RNAs CRNDE and AOX2P in adult acute myeloid leukemia. International journal of laboratory hematology, 43 (4), 732–742.
   PubMed Web of Science ®Google Scholar
• Huarte, M., 2015. The emerging role of lncRNAs in cancer. Nature medicine, 21 (11), 1253–1261.
   PubMed Web of Science ®Google Scholar
• Iyer, M.K., et al., 2015. The landscape of long noncoding RNAs in the human transcriptome. Nature genetics, 47 (3), 199–208.
   PubMed Web of Science ®Google Scholar
• Jiang, Y., Chen, J., and Chen, G., 2019. Long noncoding RNA IRAIN acts as tumor suppressor via miR-125b in multiple myeloma. Oncology letters, 18 (6), 6787–6794.
   PubMed Web of Science ®Google Scholar
• Kanduri, C., 2016. Long noncoding RNAs: Lessons from genomic imprinting. Biochimica et biophysica acta, 1859 (1), 102–111.
   PubMed Web of Science ®Google Scholar
• Kang, L., et al., 2015. Aberrant allele-switch imprinting of a novel IGF1R intragenic antisense non-coding RNA in breast cancers. European journal of cancer, 51:260–270.
   Google Scholar
• Kantarjian, H., et al., 2021. Acute myeloid leukemia: current progress and future directions. Blood Cancer journal, 11 (2), 41.
   PubMed Web of Science ®Google Scholar
• Kayser, S., and Levis, M.J., 2022. Updates on targeted therapies for acute myeloid leukaemia. British journal of haematology, 196 (2), 316–328.
   PubMed Web of Science ®Google Scholar
• Kirtonia, A., et al., 2020. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia. Journal of molecular medicine (Berlin, Germany), 98 (8), 1069–1091.
   PubMed Web of Science ®Google Scholar
• Kirtonia, A., et al., 2022. Long noncoding RNAs: A novel insight in the leukemogenesis and drug resistance in acute myeloid leukemia. Journal of cellular physiology, 237 (1), 450–465.
   PubMed Web of Science ®Google Scholar
• Lei, L., et al., 2018. Genome-wide characterization of lncRNAs in acute myeloid leukemia. Briefings in bioinformatics, 19 (4), 627–635.
   PubMed Web of Science ®Google Scholar
• Ley, T.J., et al., 2013. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. The New England journal of medicine, 368 (22), 2059–2074.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2020. Long non-coding RNA IRAIN inhibits VEGFA expression via enhancing its DNA methylation leading to tumor suppression in renal carcinoma. Frontiers in oncology, 10, 1082.
   PubMed Web of Science ®Google Scholar
• Lian, Y., et al., 2016. Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer. Tumour biology : the journal of the international society for oncodevelopmental biology and medicine, 37 (11), 14929–14937.
   PubMedGoogle Scholar
• Madan, V., et al., 2016. Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia. Leukemia, 30 (8), 1672–1681.
   PubMed Web of Science ®Google Scholar
• Marcucci, G., et al., 2014. Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score. Journal of clinical oncology : official journal of the American society of clinical oncology, 32 (6), 548–556.
   PubMed Web of Science ®Google Scholar
• Mer, A.S., et al., 2018. Expression levels of long non-coding RNAs are prognostic for AML outcome. Journal of hematology & oncology, 11 (1), 52.
   PubMedGoogle Scholar
• Metzeler, K.H., et al., 2016. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. Blood, 128 (5), 686–698.
   PubMed Web of Science ®Google Scholar
• Morlando, M., Ballarino, M., and Fatica, A., 2015. Long non-coding RNAs: new players in hematopoiesis and leukemia. Frontiers in medicine, 2, 23.
   PubMed Web of Science ®Google Scholar
• Newell, L.F., and Cook, R.J., 2021. Advances in acute myeloid leukemia. BMJ (clinical research ed.), 375, n2026.
   PubMedGoogle Scholar
• Ng, M., Heckl, D., and Klusmann, J.H., 2019. The regulatory roles of long noncoding RNAs in acute myeloid leukemia. Frontiers in oncology, 9, 570.
   PubMed Web of Science ®Google Scholar
• Papaioannou, D., et al., 2017. Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia. Haematologica, 102 (8), 1391–1400.
   PubMed Web of Science ®Google Scholar
• Pashaiefar, H., et al., 2018. Low expression of long noncoding RNA IRAIN is associated with poor prognosis in non-M3 acute myeloid leukemia patients. Genetic testing and molecular biomarkers, 22 (5), 288–294.
   PubMed Web of Science ®Google Scholar
• Quinn, J.J., and Chang, H.Y., 2016. Unique features of long non-coding RNA biogenesis and function. Nature reviews genetics, 17 (1), 47–62.
   PubMed Web of Science ®Google Scholar
• Reinmuth, N., et al., 2002. Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer. Clinical cancer research : an official journal of the American association for cancer research, 8 (10), 3259–3269.
   PubMed Web of Science ®Google Scholar
• Sanz, M.A., et al., 2009. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 113 (9), 1875–1891.
   PubMed Web of Science ®Google Scholar
• Seccareccia, E., and Brodt, P., 2012. The role of the insulin-like growth factor-I receptor in malignancy: an update. Growth hormone & IGF research : official journal of the growth hormone research society and the international IGF research society, 22 (6), 193–199.
   PubMed Web of Science ®Google Scholar
• Short, N.J., Rytting, M.E., and Cortes, J.E., 2018. Acute myeloid leukaemia. Lancet (london, England), 392 (10147), 593–606.
   PubMed Web of Science ®Google Scholar
• Sun, J., et al., 2014. A novel antisense long noncoding RNA within the IGF1R gene locus is imprinted in hematopoietic malignancies. Nucleic acids research, 42 (15), 9588–9601.
   PubMed Web of Science ®Google Scholar
• Tsai, C.H., et al., 2019. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients. EBioMedicine, 40, 240–250.
   PubMed Web of Science ®Google Scholar
• Tyner, J.W., et al., 2018. Functional genomic landscape of acute myeloid leukaemia. Nature, 562 (7728), 526–531.
   PubMed Web of Science ®Google Scholar
• Wang, J.Y., et al., 2020. Aberrant allelic-switch of antisense lncRNA IRAIN may be an early diagnostic marker in laryngeal cancer. Oncology letters, 20 (4), 65.
   PubMed Web of Science ®Google Scholar
• Wang, Y., 2019. Comprehensive long non-coding RNA expression profiling by RNA sequencing reveals potential biomarkers for acute myeloid leukemia risk. Cancer biomarkers : section A of disease markers, 26 (1), 93–108.
   PubMed Web of Science ®Google Scholar
• Wei, S., and Wang, K., 2015. Long noncoding RNAs: pivotal regulators in acute myeloid leukemia. Experimental Hematology & oncology, 5 (1), 1–7.
   PubMedGoogle Scholar